| For: | Chen QX, Zhang YB, Zeng WM, Cai YC, Lv CB, Lian MQ, Huang RJ, Lian MJ, Lian WL, Xu QH, Sun YQ, Cai LS. Efficacy and safety of sintilimab combined with nab-paclitaxel plus S-1 for neoadjuvant treatment of locally advanced gastric cancer. World J Gastrointest Surg 2025; 17(6): 106361 [PMID: 40584486 DOI: 10.4240/wjgs.v17.i6.106361] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v17/i6/106361.htm |
| Number | Citing Articles |
| 1 |
Hua-Zhen Zheng, Peng Wang, Hui-Jie Zheng, Zi-Qi Wang, Qi-Xin Li, Huan-Wei Chen, Huo-Qiang Chen, Qiu-Cheng Lei. Urinary N1, N12-diacetylspermine as a potential tumor biomarker for gastric and colorectal cancer. World Journal of Gastroenterology 2026; 32(33): 118185 doi: 10.3748/wjg.118185
|
| 2 |
Yu-Qing Cao, Meng Song, Xiang-Ming Huang, Fei-Yu Wang, Ying Peng, Jie Cao, Ai-Guo Cao, Xin-En Huang. Sintilimab Plus Nanoparticle Polymeric Micellar Paclitaxel and S-1 as First-Line Treatment in HER2-Negative Advanced Gastric Cancer: A Real-World Study. Journal of Gastrointestinal Cancer 2026; 57(1) doi: 10.1007/s12029-025-01390-x
|
| 3 |
Lorrany Larisse Costa Rodrigues, Rebeca Ferreira de Souza, Bianca Gonzaga Freitas, Leticia Gomes, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, Filipe Luis Vasconcelos Visani, Otávio Al-Alam. Perioperative Chemoimmunotherapy vs. Chemotherapy Alone for Gastroesophageal Cancer: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal Cancer 2026; 57(1) doi: 10.1007/s12029-026-01418-w
|
| 4 |
Margaret Mekuriya Bassaye, Zou Jijian, Zhou Li, Shuai Han. Long-term durable response to Sintilimab therapy in synchronous lung squamous cell carcinoma and gastric adenocarcinoma: a rare case report. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1679799
|